Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Matthew Kroh, MD, FACS, is the Director of Surgical Endoscopy in the Digestive Disease Institute at Cleveland Clinic. He is the Program Director for the Advanced Laparoscopic Surgery and Flexible Surgical Endoscopy Fellowship at the Cleveland Clinic. Dr. Kroh also holds positions with the Bariatric and Metabolic Institute and the Center for Surgical Innovation, Technology, and Education, located at the Cleveland Clinic main campus. He is the Surgery Clerkship Director in the Cleveland Clinic Lerner College of Medicine and he is currently the Director for the Center of Advanced Skills Training (CAST). He is licensed by the State Medical Board of Ohio and board-certified by the American Board of Surgery. His specialty interests include advanced laparoscopic surgery, bariatric surgery, gastrointestinal surgery, surgical endoscopy, single incision laparoscopic surgery, and robotic surgery.
After earning a Bachelor of Science degree in biology from Boston College and Master's degree from Boston University, Dr. Kroh received his medical degree from the Mount Sinai School of Medicine of New York University.
Dr. Kroh has lectured widely on laparoscopic and bariatric surgery and related topics at medical conferences across the country and the world and he has co-authored many articles and book chapters that have appeared in leading medical journals, such as the Journal of the American College of Surgeons and Surgical Endoscopy . He has been involved in numerous research projects in his field, including fluoroscopy as an adjunct to laparoscopic gastric band adjustments for morbid obesity, predictors of advanced liver disease in patients undergoing bariatric surgery, development of a novel device for endoscopic management of Barrett's esophagus, and new methods of performing less invasive laparoscopic operations including Single Incision Laparoscopic Surgery, NOTES procedures, POEM and ESD procedures, and many more.
His professional memberships include the American College of Surgeons, the American Society for Metabolic and Bariatric Surgery, the Society of American Gastrointestinal and Endoscopic Surgeons, the Association of Surgical Educators, American Society of Gastrointestinal Endoscopists, and the Central Surgical Association.
Advanced laparoscopic surgery, endoscopy, achalasia operations, anti-reflux, as well as surgery of the gastrointestinal tract, bariatric medicine, bariatric operations, bariatric surgery, endoluminal surgery, endoscopy in the obese patient, Interventional endoscopy, gastric cancer, gastrointestinal surgery, gastric surgery with focus on reflux disease, hiatal hernia, laparoscopic solid organ surgery including splenectomy and adrenalectomy, Medical education, Resident and Fellow Education, Robotic Surgery, Single incision laparoscopic surgery, weight loss surgery, Weight Management, Robotic surgery, Median arcuate ligament syndrome, Gastric pacemaker
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/26/2014, Dr. Kroh has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.